Pharmaceutical and Device

The Biotechnology Industry Organization (BIO) recently released a report entitled, “The Reimbursement Landscape for Novel…

The Washington Legal Foundation (WLF) recently published a working paper entitled, “Taking Your Medicine: Navigating…

With the amount of negative attention lately surrounding relationships between physicians and industry, some doctors have had…

The Tufts Center for the Study of Drug Development at Tufts University provides strategic information to help drug developers,…

In a speech last week at the FT Global Pharmaceutical and Biotechnology conference in London, AstraZeneca CEO David Brennan urged…

Criticism surrounding commercially supported continuing medical education (CME) has remained constant over the past several years,…

In early coal mining, miners would keep a canary in the mine as an early warning system for lack of oxygen.  An early warning that…

A recent article in Nature Reviews Drug Discovery examined the current environment for drug research and development (R&D) in…

The Chicago Tribune was one of the media sponsors who worked with ProPublica this week to publish stories about a report on…

Over the years, “wide-spread criticism of the pharmaceuti­cal industry’s extravagant marketing prac­tices and some doctors’…